| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 8780786 | Gynecologic Oncology | 2017 | 5 Pages | 
Abstract
												Among women with stage IIIC EOC, NACT is associated with both decreased rates of readmission and decreased survival compared to PDS. While selection bias may account for some of the observed differences in survival, the current focus on short-term hospital-wide quality metrics, such as postoperative readmission, in the ovarian cancer population, may be creating incentives inconsistent with long-term goals.
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Obstetrics, Gynecology and Women's Health
												
											Authors
												Emma L. Barber, Emma C. Rossi, Paola A. Gehrig, 
											